Area of research
Neurology · Pharmacology
Research interest
Research interests include Neuroinflammation and Neurodegeneration Mechanisms, Inflammatory mediators and NSAID effects, Neurological Disease Mechanisms and Treatments, and Mitochondrial Function and Pathology.
Peripheral RIPK2 degradation improves neurological outcomes after experimental ischemic stroke
Effects of global Ripk2 genetic deficiency in aged mice following experimental ischemic stroke
Tacrolimus mitigates pathological patterns in mouse models of Alzheimer’s disease
Effects of Global <i>Ripk2</i> Genetic Deficiency in Aged Mice following Experimental Ischemic Stroke
Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities
Therapeutic Benefits of Adropin in Aged Mice After Transient Ischemic Stroke via Reduction of Blood-Brain Barrier Damage
An Unexplored Role for MMP-7 (Matrix Metalloproteinase-7) in Promoting Gut Permeability After Ischemic Stroke
Adropin expression correlates with age-related neuropathologies in the human brain and improves neuroinflammation and cognitive function in aging mice
Adropin expression correlates with aging-related neuropathology in the human brain and improves neuroinflammation and cognitive function in aging mice
Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19
Age-Dependent Decrease in Adropin is Associated with Reduced Levels of Endothelial Nitric Oxide Synthase and Increased Oxidative Stress in the Rat Brain
Selective degradation of BET proteins with dBET1 attenuates lipopolysaccharide‐induced pro‐inflammatory response in microglia
Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A<sub>4</sub> analog: Protective mechanisms and long‐term effects on neurological recovery
Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke